US Bancorp DE Has $22.06 Million Stock Position in The Allstate Co. (NYSE:ALL)

US Bancorp DE cut its holdings in The Allstate Co. (NYSE:ALL) by 2.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 116,296 shares of the insurance provider’s stock after selling 2,550 shares during the period. US Bancorp DE’s holdings in Allstate were worth $22,056,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in ALL. Northwest Investment Counselors LLC acquired a new position in shares of Allstate during the 3rd quarter worth about $28,000. Versant Capital Management Inc boosted its position in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 78 shares during the last quarter. Family Firm Inc. bought a new position in Allstate in the second quarter valued at approximately $38,000. MCF Advisors LLC increased its position in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares during the last quarter. Finally, First Command Advisory Services Inc. bought a new stake in shares of Allstate during the 2nd quarter worth approximately $58,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Wall Street Analyst Weigh In

ALL has been the topic of a number of recent analyst reports. The Goldman Sachs Group boosted their target price on shares of Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a report on Thursday, August 15th. Keefe, Bruyette & Woods upped their target price on shares of Allstate from $199.00 to $208.00 and gave the company an “outperform” rating in a report on Monday, August 12th. TD Cowen raised their target price on shares of Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. Wells Fargo & Company lowered their price target on Allstate from $177.00 to $175.00 and set an “equal weight” rating on the stock in a research report on Friday, August 16th. Finally, UBS Group raised their price objective on Allstate from $215.00 to $216.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Allstate has an average rating of “Moderate Buy” and a consensus price target of $207.19.

Insider Buying and Selling

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock worth $34,967,665 in the last three months. 1.80% of the stock is owned by corporate insiders.

Allstate Price Performance

ALL stock opened at $184.18 on Friday. The company’s 50-day moving average price is $188.87 and its two-hundred day moving average price is $175.16. The Allstate Co. has a 12 month low of $127.93 and a 12 month high of $198.79. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.49. The firm has a market cap of $48.63 billion, a P/E ratio of 11.93, a P/E/G ratio of 1.91 and a beta of 0.48.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 27.74% and a net margin of 6.77%. Allstate’s revenue was up 14.7% compared to the same quarter last year. During the same period last year, the firm posted $0.81 earnings per share. On average, analysts anticipate that The Allstate Co. will post 14.16 earnings per share for the current fiscal year.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.